quinuclidines has been researched along with moxifloxacin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brealey, N; Kelleher, D; Mehta, R; Preece, A; Tombs, L | 1 |
| Green, M; Mehta, R; Patel, B; Wagg, J | 1 |
2 trial(s) available for quinuclidines and moxifloxacin
| Article | Year |
|---|---|
A randomized, placebo- and moxifloxacin-controlled thorough QT study of umeclidinium monotherapy and umeclidinium/vilanterol combination in healthy subjects.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adult; Benzyl Alcohols; Chlorobenzenes; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Dry Powder Inhalers; Female; Fluoroquinolones; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Muscarinic Antagonists; Quinuclidines; Single-Blind Method; Young Adult | 2014 |
Concentration-QT analysis of the randomized, placebo- and moxifloxacin-controlled thorough QT study of umeclidinium monotherapy and umeclidinium/vilanterol combination in healthy subjects.
Topics: Adrenergic beta-2 Receptor Agonists; Adult; Benzyl Alcohols; Chlorobenzenes; Cross-Over Studies; Drug Combinations; Female; Fluoroquinolones; Healthy Volunteers; Humans; Male; Middle Aged; Moxifloxacin; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Tablets; Topoisomerase II Inhibitors; Young Adult | 2016 |